In this example, the aggregation of magnetic nanoparticles labeled with DiR is monitored in real time. Tumor microvasculature is labeled using FITC-Dextran.
In this example, Everaert et al. study the survival and homing capacity of BMSCs in a hindlimb ischemia mouse model in the presence or absence of immunosuppression treatment (CsA). Different injection routes are tested: intramuscular (IM) and intra-arterial (IA).